KARAM MEDICAL
KARAM MEDICAL is a Spain-based specialty medical device distributor for plastic surgery, aesthetic medicine, and regenerative medicine, distributing Puregraft fat grafting systems, Motiva breast implants, Qrem Cytokine regenerative treatments, and Nouvys collagen skincare to clinics and consumers.
- Company typePrivate
- Founded2004
- HeadquartersAlella, Spain
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What KARAM MEDICAL does
KARAM MEDICAL is a Spanish medical device distributor headquartered in Alella, Barcelona, specializing in surgical materials for plastic surgery, aesthetic medicine, and regenerative medicine. The company distributes an exclusive four-brand portfolio: Puregraft (an FDA-approved and CE0120-marked autologous fat grafting system using proprietary lipodialysis technology that processes fat grafts within the sterile field in under 15 minutes), Motiva breast implants from Establishment Labs (featuring SilkSurface/VelvetSurface nano-surfaces, TrueMonobloc membrane design, Q inside Safety Technology for external implant identification, and ProgressiveGel fills), Qrem Cytokine (a patented bioengineering system using a QDevice desktop lab and Q-Kit single-use sterile kit to produce Autologous Serum Rich in Cytokines for tissue regeneration), and Nouvys (a collagen peptide-based skin rejuvenation product launched in 2024). The underlying technologies are licensed or distributed under partnerships rather than developed in-house by KARAM MEDICAL.
The company operates a hybrid go-to-market model combining a B2C WooCommerce-powered e-commerce storefront for individual consumers purchasing post-operative lingerie and skincare products with a B2B direct/field sales channel targeting plastic surgery clinics, aesthetic medicine professionals, and wholesale buyers across Spain (contact routed through [email protected]). Marketing is executed through the company website, Facebook, Instagram, scientific article publications, and product demonstration videos. The business is exclusively Spanish in geographic scope, with founders bringing over 20 years of medical sector experience. No revenue, headcount growth, or funding signals are disclosed beyond a stated headcount of 6 employees.
KARAM MEDICAL firmographics
Firmographics- Name
- KARAM MEDICAL
- Legal name
- KARAM MEDICAL
- Website
- https://karammedical.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- KARAM MEDICAL is a Spain-based specialty medical device distributor for plastic surgery, aesthetic medicine, and regenerative medicine, distributing Puregraft fat grafting systems, Motiva breast implants, Qrem Cytokine regenerative treatments, and Nouvys collagen skincare to clinics and consumers.
- Ownership category
- akta.pro rank
KARAM MEDICAL industry classification
Industry- Product category
- Medical Device Distribution
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where KARAM MEDICAL is headquartered
LocationHeadquarters
- HQ city
- Alella
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
KARAM MEDICAL business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Distribution: Distribution of specialized medical devices for plastic surgery, aesthetic medicine, and regenerative medicine including breast implants, fat grafting systems, cytokine treatments, and post-operative products. Sales conducted through e-commerce for consumers and direct contact for professional buyers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Consumer e-commerce pricing for post-operative lingerie |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
KARAM MEDICAL product offering
Product offeringCore offering
KARAM MEDICAL distributes specialised surgical medical devices and dermatological products for plastic surgery, aesthetic medicine, and regenerative medicine to clinics and post-operative patients across Spain. Its portfolio includes Puregraft autologous fat grafting systems, Motiva breast implants, QREM Cytokine regenerative systems, and Nouvys collagen peptide skincare, sourced through exclusive distribution partnerships with manufacturers.
Product overview
KARAM MEDICAL is a medical device distributor specializing in surgical materials for Plastic, Aesthetic, and Regenerative Medicine. The company distributes a portfolio of four distinct products: Puregraft (autologous fat grafting system for lipofilling procedures), Motiva breast implants (silicone mammary prostheses with advanced surface technologies), Nouvys (collagen peptide-based aesthetic dermatology product), and QREM Cytokine (autologous serum system for tissue regeneration). These products serve plastic surgeons and aesthetic medicine practitioners, covering the full workflow from fat transfer procedures to breast augmentation and skin rejuvenation treatments.
Differentiator
Problem solved
Functional benefit
Brands
- Puregraft: Autologous fat grafting system for fat transfer procedures in plastic and aesthetic surgery
- Motiva
- Nouvys
- Qrem Citoquinas
Products and services
- Puregraft System Autologous fat grafting system indicated for fat transfers, enabling preparation of fat grafts within the sterile field in less than 15 minutes. Available in 50ml, 250ml, and 850ml sizes for facial, body, and large-volume treatments respectively. Marketed to plastic surgeons and aesthetic medicine practitioners in Spain.
- Motiva Breast Implants Sixth-generation mammary implants featuring TrueMonobloc membrane design, SilkSurface and VelvetSurface nano-surfaces, Q inside Safety Technology, and ProgressiveGel fills (ProgressiveGel, ProgressiveGel PLUS, and ProgressiveGel Ultima). The Ergonomix line offers TrueTissue Dynamics for natural appearance and feel. CE-marked with long-term implantable Nusil medical-grade silicone. Sold to plastic surgeons and aesthetic clinics in Spain.
- Nouvys Collagen peptide-based skin rejuvenation product containing bioactive low molecular weight peptides optimized to improve skin cell structure. Addresses dermatoelastosis, photodamage, skin laxity, dyschromia, and volume loss through stimulation of native collagen and elastin synthesis. Targeted at aesthetic medicine practitioners and post-aesthetic-procedure patients.
- QREM Cytokine System Bioengineering system for obtaining cytokines involved in tissue regeneration. Produces Autologous Cytokine-Rich Serum (SARC) through a patented biological process. Consists of a closed automated desktop device (QDevice) and single-use sterile kit (Q-Kit) that yields 8-12ml of SARC containing IL-10, TGF-β1, PDGF, and IGF-1 cytokines. Sold to regenerative medicine practitioners in Spain.
Companies that use KARAM MEDICAL
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
KARAM MEDICAL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
KARAM MEDICAL partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Puregraft LLCcoreOfficial exclusive distributor of Puregraft products in Spain. Puregraft is a FDA-approved and CE0120 marked fat grafting system used for autologous fat transfer procedures in plastic and reconstructive surgery. The system enables rapid preparation of large volume fat grafts (10-850mL) within the sterile field.
- Establishment Labs (Motiva Implant Matrix)coreDistributor of Motiva breast implant products in Spain. All Motiva products carry CE conformity marking and use only long-term implantable Nusil medical-grade silicone. Products include Ergonomix implants with SilkSurface/VelvetSurface technology and Q inside Safety Technology.
- QREM RegenerativecoreDistributor of Qrem Cytokine products including the QDevice lab system and Q-Kit for producing Autologous Serum Rich in Cytokines (SARC). The system enables tissue regeneration treatments through a patented biological process.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
KARAM MEDICAL competitors and assessment
Company assessmentDirect peers
- Establishment Labs: Manufacturer of the Motiva breast implants that Karam Medical distributes in Spain. Directly comparable product category (breast implants/aesthetic surgery devices) and the primary upstream partner relationship.
- Sebbin: French breast implant and aesthetic medical device manufacturer. Overlapping product category (breast implants, surgical aesthetic devices) and serves a similar clinical customer base across Europe.
- GC Aesthetics: Ireland-based manufacturer of breast implants and aesthetic surgery products. Competes head-to-head with Motiva in the same clinical category that Karam Medical serves, making it a directly comparable aesthetic medical device company.
- Sinclair Pharma: Specialist aesthetics company developing and commercializing facial aesthetics, dermal fillers, and biostimulators. Comparable aesthetic medicine focus and overlapping target customer (plastic surgeons, dermatologists, aesthetic practitioners).
- Polytech Health & Aesthetics: German manufacturer of silicone breast implants and aesthetic surgery devices. Competes directly in the breast implant and aesthetic medical device space that Karam distributes.
- IBSA Farmaceutici: Swiss pharmaceutical company with strong aesthetics and regenerative medicine franchises (hyaluronic acid fillers, regenerative products). Comparable medical aesthetics and regenerative medicine focus targeting similar clinician customers.
Broad incumbents
- Mentor (Johnson & Johnson MedTech): Large established manufacturer of breast implants and aesthetic surgery products within J&J. Directly competes with Motiva implants that Karam distributes, but operates as a broad incumbent with a much wider portfolio beyond aesthetics.
- Allergan Aesthetics (AbbVie): Global aesthetics leader offering breast implants, fillers, toxins, and skincare. Operates broadly in the same aesthetic medical category that Karam serves, but at massive scale with a diversified product portfolio.
- Galderma: Global dermatology and aesthetics company with injectable, skincare, and therapeutic dermatology products. Comparable aesthetics/dermatology customer overlap, but at a much larger incumbent scale.
Regional players
- Mesoestetic: Spanish-headquartered medical aesthetics and skincare company with strong presence in Iberia and Latin America. Same regional market (Spain) and overlapping aesthetic medical/skin rejuvenation customer base as Karam Medical.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights1 record
Customer concentration
KARAM MEDICAL social profiles
Digital presenceKARAM MEDICAL compliance and trust
Trust signalCompliance3 records
KARAM MEDICAL financial estimates
Financial estimateRevenue estimate
Valuation estimate
KARAM MEDICAL leadership team
Management profileNumber of profiles
KARAM MEDICAL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KARAM MEDICAL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KARAM MEDICAL
What does KARAM MEDICAL do?
KARAM MEDICAL distributes specialised surgical medical devices and dermatological products for plastic surgery, aesthetic medicine, and regenerative medicine to clinics and post-operative patients across Spain. Its portfolio includes Puregraft autologous fat grafting systems, Motiva breast implants, QREM Cytokine regenerative systems, and Nouvys collagen peptide skincare, sourced through exclusive distribution partnerships with manufacturers.
Is KARAM MEDICAL a public or private company?
KARAM MEDICAL is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was KARAM MEDICAL founded?
KARAM MEDICAL was founded in 2004. It employs 1 to 10 people.
Where is KARAM MEDICAL based?
KARAM MEDICAL is headquartered in Alella, Spain, in the Europe region.
How does KARAM MEDICAL make money?
One revenue line is on record: medical Device Distribution.
Who are KARAM MEDICAL's main competitors?
Direct peers on record are Establishment Labs, Sebbin, GC Aesthetics, Sinclair Pharma, Polytech Health & Aesthetics and IBSA Farmaceutici. Broad incumbents are Mentor (Johnson & Johnson MedTech), Allergan Aesthetics (AbbVie) and Galderma. Mesoestetic is listed as a regional player.
Does KARAM MEDICAL have an API?
No public API is recorded for KARAM MEDICAL.
What industry is KARAM MEDICAL in?
KARAM MEDICAL's product category is Medical Device Distribution. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 3391 and its SIC code is 3841.